Effects of dopamine agonists on delayed response performance in chronic low-dose MPTP-treated monkeys
- 31 May 1994
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 48 (1) , 235-240
- https://doi.org/10.1016/0091-3057(94)90522-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeysBrain Research, 1993
- Sensorimotor disinhibition in Parkinson's disease: Effects of levodopaAnnals of Neurology, 1992
- Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeysBrain Research, 1990
- Distractibility in Early Parkinson's DiseaseCortex, 1990
- Selective D-1 dopamine receptor agonist treatment of parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- FRONTAL LOBE DYSFUNCTION IN PARKINSON'S DISEASEBrain, 1986
- Cognitive performance in early Parkinson's diseaseActa Neurologica Scandinavica, 1986
- Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonismNeuroscience Letters, 1985
- The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmosetNeuroscience Letters, 1985
- CSF monoamine metabolites in children with minimal brain dysfunction: Evidence for alteration of brain dopamineThe Journal of Pediatrics, 1977